These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9225010)
1. In vitro production of antigen-specific T cells from unprimed mice: role of dexamethasone and anti-IL-10 antibodies. Dozmorov I; Miller RA Cell Immunol; 1997 Jun; 178(2):187-96. PubMed ID: 9225010 [TBL] [Abstract][Full Text] [Related]
2. Generation of antigen-specific Th2 cells from unprimed mice in vitro: effects of dexamethasone and anti-IL-10 antibody. Dozmorov IM; Miller RA J Immunol; 1998 Mar; 160(6):2700-5. PubMed ID: 9510169 [TBL] [Abstract][Full Text] [Related]
3. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type. DeKruyff RH; Fang Y; Umetsu DT J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971 [TBL] [Abstract][Full Text] [Related]
4. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. Croft M; Bradley LM; Swain SL J Immunol; 1994 Mar; 152(6):2675-85. PubMed ID: 7908301 [TBL] [Abstract][Full Text] [Related]
5. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo. Mejri N; Brossard M Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202 [TBL] [Abstract][Full Text] [Related]
6. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone. Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989 [TBL] [Abstract][Full Text] [Related]
7. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. Gramaglia I; Weinberg AD; Lemon M; Croft M J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675 [TBL] [Abstract][Full Text] [Related]
8. Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production. Bocek P; Foucras G; Paul WE J Exp Med; 2004 Jun; 199(12):1619-30. PubMed ID: 15210741 [TBL] [Abstract][Full Text] [Related]
9. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'. Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064 [TBL] [Abstract][Full Text] [Related]
10. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse. Margenthaler JA; Flye MW J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414 [TBL] [Abstract][Full Text] [Related]
11. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. Rogers PR; Grey HM; Croft M J Immunol; 1998 Apr; 160(8):3698-704. PubMed ID: 9558070 [TBL] [Abstract][Full Text] [Related]
12. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine. Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254 [TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance by IL-10-treated dendritic cells. Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
16. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo. Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647 [TBL] [Abstract][Full Text] [Related]
17. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104 [TBL] [Abstract][Full Text] [Related]
18. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. Macaulay AE; DeKruyff RH; Umetsu DT J Immunol; 1998 Feb; 160(4):1694-700. PubMed ID: 9469426 [TBL] [Abstract][Full Text] [Related]
19. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. DeKruyff RH; Fang Y; Umetsu DT J Immunol; 1998 Mar; 160(5):2231-7. PubMed ID: 9498762 [TBL] [Abstract][Full Text] [Related]
20. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. George TC; Bilsborough J; Viney JL; Norment AM Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]